In a new clinical practice guideline, recommendations are presented for the surgical management of chronic rhinosinusitis in adults.

In patients with chronic rhinosinusitis with nasal polyps, factors including baseline antibiotic use and asthma impacted the ...

Shares of Lyra Therapeutics Inc. soared more than 310% on data from its second phase III trial testing drug-device candidate ...

Jennifer J. Shin, M.D., from Harvard Medical School in Boston, and colleagues developed 11 key action statements to aid clinicians in the surgical management of chronic rhinosinusitis in adults.

LYR-210 demonstrated statistically significant improvement compared to sham control in key symptoms of chronic rhinosinusitis ...

Lyra's LYR-210 met key goals in a Phase 3 trial for chronic rhinosinusitis, showing early and sustained symptom relief with a ...

The American Academy of Otolaryngology–Head and Neck Surgery Foundation (AAO-HNSF) published the new Clinical Practice Guideline (CPG): Surgical Management of Chronic Rhinosinusitis today in ...

Chronic rhinosinusitis is inflammation of the sinuses and nasal passages that lasts at least 12 weeks. It causes ongoing symptoms, such as stuffy nose and facial pain or pressure. Although the ...

Lyra Therapeutics stock surged in premarket trading after announcing positive Phase 3 trial results for a key treatment.

The issuer is solely responsible for the content of this announcement. Taiwan High Court finds school responsible for student ...

What makes the case unique: Since the 1930s, exostoses in the ear canal have been associated with surfing and other water ...